1. Academic Validation
  2. Tumor-expressed B7-H3 promotes vasculogenic mimicry formation rather than angiogenesis in non-small cell lung cancer

Tumor-expressed B7-H3 promotes vasculogenic mimicry formation rather than angiogenesis in non-small cell lung cancer

  • J Cancer Res Clin Oncol. 2023 May 2. doi: 10.1007/s00432-023-04790-3.
Xingyu Fan # 1 2 Junfeng Huang # 1 2 Bingqi Hu 1 2 Jing Zhou 1 2 Liwen Chen 3 4
Affiliations

Affiliations

  • 1 Department of Laboratory Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei, China.
  • 2 Research Center for Translational Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei, China.
  • 3 Department of Laboratory Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei, China. [email protected].
  • 4 Research Center for Translational Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei, China. [email protected].
  • # Contributed equally.
Abstract

Background: Vasculogenic mimicry (VM), an alternative microvascular circulation independent of angiogenesis, is formed by aggressive Cancer cells. Tumor-expressed B7-H3 has been reported to promote VM formation in hepatocellular carcinoma and modulate angiogenesis in breast Cancer and colorectal Cancer. However, its effects on VM generation and angiogenesis in non-small cell Lung Cancer (NSCLC) remained to be elucidated.

Methods: CRISPR/Cas9-mediated B7-H3 knockout (KO) was conducted in NSCLC A549 and H3255 cells. The expression of VM-related proteins, including vascular endothelial (VE)-cadherin and matrix metalloproteinase 14 (MMP14), and the secretion of vascular endothelial growth factor (VEGF) were measured by western blotting and chemiluminescence assay in both B7-H3 KO and mock-edited A549 and H3255 cells. To examine VM formation, a three-dimensional (3D) culture model was used for B7-H3 KO and mock A549 and H3255 cells. For in vivo analysis, xenograft mice models were established using B7-H3 KO and mock-edited A549 cells, and immunohistochemical (CD31) and histochemical (periodic acid-Schiff, PAS) double staining were performed to identify VM and endothelial vessels in tumor tissues. Finally, specific signaling inhibitors were used to analyze B7-H3-induced signaling pathway responsible for VE-cadherin and MMP14 expression and VM generation.

Results: Higher expression of B7-H3 was associated with a worse prognosis and more advanced T-category in NSCLC. CRISPR/Cas9-mediated B7-H3 KO in A549 and H3255 cells led to decreased expression of VE-cadherin and MMP14; however, the secretion of VEGF by the two cell lines remained unchanged. In the 3D Cell Culture model, both B7-H3 KO A549 and H3255 cells showed a significant reduction in the formation of capillary-like tubular structures compared to mock-edited cells. In the in vivo xenograft model, mock-edited A549 cells formed excessive PAS+ CD31- VM channels, while B7-H3 KO restrained VM formation in the xenograft tumors. However, no significant differences were found in CD31+ endothelial vessels between xenografts formed by B7-H3 KO and mock-edited A549 cells. Finally, we analyzed the signaling pathway responsible for B7-H3-induced VM formation and found that selective inhibition of the phosphoinositide 3-kinase(PI3K)/protein kinase B (Akt) hyperactivation by LY294002 was associated with decreased expression of MMP14 and VE-cadherin, and in vitro VM formation by both A549 and H3255 cells.

Conclusions: Tumor-expressed B7-H3 acts via PI3K/Akt signaling pathway to promote VM formation by NSCLC cells while bears no effects on angiogenesis in NSCLC.

Keywords

B7-H3; EMT; MMP14; NSCLC; VE-cadherin; Vasculogenic mimicry.

Figures
Products